70. Environ Pollut. 2018 Jun;237:559-568. doi: 10.1016/j.envpol.2018.02.065. Epub2018 Mar 15.Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain).García-Pérez J(1), Lope V(2), Pérez-Gómez B(3), Molina AJ(4), Tardón A(5), DíazSantos MA(6), Ardanaz E(7), O'Callaghan-Gordo C(8), Altzibar JM(9), Gómez-AceboI(10), Moreno V(11), Peiró R(12), Marcos-Gragera R(13), Kogevinas M(14), AragonésN(15), López-Abente G(16), Pollán M(17).Author information: (1)Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Avda. Monforte de Lemos 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain. Electronic address: jgarcia@isciii.es.(2)Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Avda. Monforte de Lemos 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain. Electronic address: vicarvajal@isciii.es.(3)Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Avda. Monforte de Lemos 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain. Electronic address: bperez@isciii.es.(4)Research Group on Gene-Environment Interactions and Health, Institute ofBiomedicine (IBIOMED), University of León, Campus Vegazana s/n, 24071, León,Spain. Electronic address: ajmolt@unileon.es.(5)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo,Facultad de Medicina, Planta 7, Campus de El Cristo B, 33006, Oviedo, Spain.Electronic address: atardon@uniovi.es.(6)Centro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad deHuelva, Campus Universitario de El Carmen, 21071, Huelva, Spain. Electronicaddress: alguacil@dbasp.uhu.es.(7)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; Instituto de Salud Pública de Navarra, IdiSNA - Navarra Institute forHealth Research, C/Leyre 15, 31003, Pamplona, Spain. Electronic address:me.ardanaz.aicua@cfnavarra.es.(8)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; ISGlobal, Carrer del Doctor Aiguader 88, 08003, Barcelona, Spain; PompeuFabra University (UPF), Plaça de la Mercè 10-12, 08002, Barcelona, Spain.Electronic address: cristina.ocallaghan@isglobal.org.(9)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; Breast Cancer Screening Program, Osakidetza - Basque Health Service,Sancho el Sabio 35, 20010 San Sebastián, Spain. Electronic address:JONEMIREN.ALTZIBARAROTZENA@osakidetza.eus.(10)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; Universidad de Cantabria - IDIVAL, Avenida Cardenal Herrera Oria s/n,39011 Santander, Spain. Electronic address: ines.gomez@unican.es.(11)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; Cancer Prevention and Control Program, Catalan Institute of Oncology,Avinguda de la Granvia de l'Hospitalet 199-203, 08908, Hospitalet de Llobregat,Spain; Department of Clinical Sciences, Faculty of Medicine, University ofBarcelona, Gran Via de les Corts Catalanes 585, 08007, Barcelona, Spain;Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical ResearchInstitute (IDIBELL), Gran Via de l'Hospitalet 199, 08908, Hospitalet deLlobregat, Spain. Electronic address: v.moreno@iconcologia.net.(12)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana FISABIO-Salud Pública - Foundation for the Promotion ofHealth and Biomedical Research of Valencian Region (FISABIO), Avda. de Catalunya 21, 46020, Valencia, Spain. Electronic address: peiro_ros@gva.es.(13)Epidemiology Unit and Girona Cancer Registry (UERCG), Oncology CoordinationPlan, Department of Health, Autonomous Government of Catalonia, Catalan Instituteof Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), University ofGirona, Carrer del Sol 15, 17004 Girona, Spain. Electronic address:rmarcos@iconcologia.net.(14)Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain; ISGlobal, Carrer del Doctor Aiguader 88, 08003, Barcelona, Spain; PompeuFabra University (UPF), Plaça de la Mercè 10-12, 08002, Barcelona, Spain; IMIM(Hospital del Mar Medical Research Institute), Dr. Aiguader 88, 08003, Barcelona,Spain. Electronic address: manolis.kogevinas@isglobal.org.(15)Epidemiology Section, Public Health Division, Department of Health of Madrid,C/ San Martín de Porres 6, 28035, Madrid, Spain; Consortium for BiomedicalResearch in Epidemiology & Public Health (CIBER Epidemiología y Salud Pública -CIBERESP), Avda. Monforte de Lemos 3-5, Madrid, Spain. Electronic address:nuria.aragones@salud.madrid.org.(16)Cancer and Environmental Epidemiology Unit, National Center for Epidemiology,Carlos III Institute of Health, Avda. Monforte de Lemos 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain. Electronic address: glabente@isciii.es.(17)Cancer and Environmental Epidemiology Unit, National Center for Epidemiology,Carlos III Institute of Health, Avda. Monforte de Lemos 5, 28029, Madrid, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBEREpidemiología y Salud Pública - CIBERESP), Avda. Monforte de Lemos 3-5, Madrid,Spain. Electronic address: mpollan@isciii.es.Breast cancer is the most frequent tumor in women worldwide, althoughwell-established risk factors account for 53%-55% of cases. Therefore, other riskfactors, including environmental exposures, may explain the remaining variation. Our objective was to assess the relationship between risk of breast cancer andresidential proximity to industries, according to categories of industrial groupsand specific pollutants released, in the context of a population-basedmulticase-control study of incident cancer carried out in Spain (MCC-Spain).Using the current residence of cases and controls, this study was restricted tosmall administrative divisions, including both breast cancer cases (452) andcontrols (1511) in the 10 geographical areas recruiting breast cancer cases.Distances were calculated from the respective woman's residences to the 116industries located in the study area. We used logistic regression to estimateodds ratios (ORs) and 95% confidence intervals (95%CIs) for categories ofdistance (between 1 km and 3 km) to industrial plants, adjusting for matchingvariables and other confounders. Excess risk (OR; 95%CI) of breast cancer wasfound near industries overall (1.30; 1.00-1.69 at 3 km), particularly organicchemical industry (2.12; 1.20-3.76 at 2.5 km), food/beverage sector (1.87;1.26-2.78 at 3 km), ceramic (4.71; 1.62-13.66 at 1.5 km), surface treatment with organic solvents (2.00; 1.23-3.24 at 3 km), and surface treatment of plastic and metals (1.51; 1.06-2.14 at 3 km). By pollutants, the excess risk (OR; 95%CI) was detected near industries releasing pesticides (2.09; 1.14-3.82 at 2 km), anddichloromethane (2.09; 1.28-3.40 at 3 km). Our results suggest a possibleincreased risk of breast cancer in women living near specific industrial plantsand support the need for more detailed exposure assessment of certain agentsreleased by these plants.Copyright © 2018 Elsevier Ltd. All rights reserved.DOI: 10.1016/j.envpol.2018.02.065 PMID: 29524878  [Indexed for MEDLINE]